Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study

  1. Seijas-Amigo, J.
  2. Mauriz-Montero, M.ªJ.
  3. Suarez-Artime, P.
  4. Gayoso-Rey, M.
  5. Estany-Gestal, A.
  6. Casas-Martínez, A.
  7. González-Freire, L.
  8. Rodriguez-Vazquez, A.
  9. Pérez-Rodriguez, N.
  10. Villaverde-Piñeiro, L.
  11. Castro-Rubinos, C.
  12. Espino-Faisán, E.
  13. Rodríguez-Mañero, M.
  14. Cordero, A.
  15. González-Juanatey, J.R.
  16. Paz-Couce, A.
  17. Rodriguez-Penas, D.
  18. Cardeso-Paredes, B.
  19. Seoane-Blanco, A.
  20. Moure-Gonzalez, M.
  21. Soler-Martín, R.
  22. Margusino-Framiñan, L.
  23. Suarez-Rodriguez, A.
  24. Rodriguez-Cobos, M.
  25. Rojo-Valdés, J.
  26. Zarra-Ferro, I.
  27. Lorenzo-Lorenzo, K.
  28. Casanova-Martinez, C.
  29. Crespo-Diz, C.
  30. Dominguez-Guerra, M.
  31. González-Pereira, M.E.
  32. Anido-García, M.
  33. Tajes-Gonzalez, I.M.
  34. Mozo-Peñalver, H.
  35. Silva-Lopez, A.
  36. Rodriguez-Sanchez, J.L.
  37. García-Verde, M.J.
  38. Show all authors +
Journal:
American Journal of Cardiovascular Drugs

ISSN: 1179-187X,  1175-3277

Year of publication: 2023

Volume: 23

Issue: 5

Pages: 583-593

Type: Article

DOI: 10.1007/S40256-023-00604-6 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus